Investing-News.Com
Information for Investors

Internet Search		Stock Search

ELITE PHARMA INC, (ELI) Stock Rating Learn More

Our Overall Rating on ELITE PHARMA INC, ELI is Not Available

Elite Pharmaceuticals, Inc. engages in the research, development, and licensing of proprietary controlled release drug delivery systems and products. The companys products are in various stages of development and testing. Elite entered into an agreement with Purdue Pharma LP to evaluate certain of its abuse resistance technology and to negotiate a license to develop and commercialize oxycodone products under the technology in May 2004. The company was incorporated in 1997 and is based in Northvale, New Jersey.

Our Not Available Rating on ELI was issued on 11/21/2008

Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Sponsored Links:

Software Forces ELITE PHARMA INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in ELITE PHARMA INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on ELITE PHARMA INC. This software is specially designed to give precision entry and exit points on ELITE PHARMA INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When ELITE PHARMA INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even ELITE PHARMA INC, if they make the cut.
Click Here & Learn To Pick Winners In An Uncertain Market

Get Quotes and Research for ELITE PHARMA INC at Investing-News.Com

Latest Headlines